Erythrocin Lactobionate
Active substance: erythromycin lactobionate
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ERYTHROMYCIN LACTOBIONATE 500 mg/10mL
United StatesActive
Marketing holder: Hospira, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ERYTHROMYCIN LACTOBIONATE · 500 mg/10mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-cc25-78d8-b3a7-ea378963e949,01a12096-f4f2-717c-bb50-d81bd859c976,01a1209c-0be9-7903-aa3f-d2d5f3635db3,01a1209d-f1d6-74fc-93ab-10384f66a989;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0409-6482
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0409-6482 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0409-6482 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0409-6482 · Verified 2026-10-09 · open in source